Long Term Follow up of the Titanium Modular Revision Hip System up (TinT 10) Levels

ConditionHip Surgery
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRobert Jones and Agnes Hunt Orthopaedic and District NHS Trust

About this trial

Patients are to be approached to attend clinic who have been identified as being implanted with either a Lima Corporate Delta Revision TT, Delta One TT or the Delta Multihole Systems hip systems between 2011 and 2015, a minimum of 10 years since hip surgery. They will be x-rayed (AP pelvis and a lateral view) and have a clinical review in clinic.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

All adult patients who had Lima Corporate modular titanium acetabular component implants implanted between 2011 and 2015.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • x-ray

    Radiation

    AP view of pelvis

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: Only 1 arm for the study1 intervention

Trial outcomes

Primary outcomes

1

The survivourship of the modular acetabular hip system at 10 years post-op

This study will be the largest study to look at the survivorship of this acetabular system. Survivorship will be to the point of revision and clinical outcome survivorship is to the point of radiological loosening and PROMs data collection.

Time frame
Participants will be invited to attend a one time clinic visit, after which their participation in the study has ended.

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: